1 Min Read
Nov 27 (Reuters) - SCANDINAVIAN REAL HEART AB:
* GETS APPROVED FOR PHASE TWO OF PRECLINICAL ANIMAL STUDY DURING Q1 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.